Bladder Cancer
Matritech's bladder cancer test can be used to screen high-risk groups
Published in Biotech Business Week, September 25th, 2006
Bladder cancer is curable when found early, but few recognize the symptoms early enough to seek testing. Unfortunately, one in four bladder cancers is diagnosed when it is already advanced, reducing the chances of survival and requiring expensive treatment. This may be about to change.
The urine-based NMP22 BladderChek Test, which has been reported to be cost effective for screening high risk groups because of its low cost and high accuracy, is being used in local programs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Healthcare Costs
Survey forecasts health plan costs down but drug plan costs to outpace inflation in 2007 - Market Analysis
Booming European enteral nutrition market provides opportunities for ingredient suppliers - Market Analysis
Global market for DNA oligos tops $700 million annually - Market Analysis
Research and Markets report finds healthcare in China to be extremely uneven - Neuroscience
Alzheimer, Parkinson, dementia targeted in protein study - Alzheimer Disease
Accera initiates phase II trial for age associated memory impairment therapy - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
